UnitedHealth Group Incorporated [NYSE: UNH] closed the trading session at $541.57 on 08/25/22. The day’s price range saw the stock hit a low of $531.25, while the highest price level was $542.02. The company report on August 17, 2022 that UnitedHealth Group Board Authorizes Payment of Quarterly Dividend.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $1.65 per share, to be paid September 20, 2022, to common stock shareholders of record as of the close of business September 12, 2022.
The stocks have a year to date performance of 7.85 percent and weekly performance of -0.67 percent. The stock has been moved at 18.79 percent over the last six months. The stock has performed 1.30 percent around the most recent 30 days and changed 8.73 percent over the most recent 3-months.
If compared to the average trading volume of 3.06M shares, UNH reached to a volume of 1964768 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about UnitedHealth Group Incorporated [UNH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNH shares is $573.24 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Loop Capital have made an estimate for UnitedHealth Group Incorporated shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 17, 2022. The new note on the price target was released on May 27, 2022, representing the official price target for UnitedHealth Group Incorporated stock. Previously, the target price had yet another raise to $535, while Goldman analysts kept a Buy rating on UNH stock.
The Average True Range (ATR) for UnitedHealth Group Incorporated is set at 9.04, with the Price to Sales ratio for UNH stock in the period of the last 12 months amounting to 1.64. The Price to Book ratio for the last quarter was 6.97, with the Price to Cash per share for the same quarter was set at 26.46. Price to Free Cash Flow for UNH in the course of the last twelve months was 34.01.
UNH stock trade performance evaluation
UnitedHealth Group Incorporated [UNH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.67. With this latest performance, UNH shares gained by 1.30% in over the last four-week period, additionally plugging by 18.79% over the last 6 months – not to mention a rise of 29.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNH stock in for the last two-week period is set at 55.95, with the RSI for the last a single of trading hit 54.03, and the three-weeks RSI is set at 56.44 for UnitedHealth Group Incorporated [UNH]. The present Moving Average for the last 50 days of trading for this stock 521.38, while it was recorded at 541.34 for the last single week of trading, and 495.34 for the last 200 days.
UnitedHealth Group Incorporated [UNH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and UnitedHealth Group Incorporated [UNH] shares currently have an operating margin of +8.33. UnitedHealth Group Incorporated’s Net Margin is presently recorded at +6.01.
Return on Equity for this stock inclined to 25.19, with Return on Assets sitting at 8.30.
Earnings per share (EPS) analysis for UnitedHealth Group Incorporated [UNH] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for UNH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for UnitedHealth Group Incorporated go to 14.38%.
UnitedHealth Group Incorporated [UNH]: Insider Ownership positions
There are presently around $447,105 million, or 90.50% of UNH stock, in the hands of institutional investors. The top three institutional holders of UNH stocks are: VANGUARD GROUP INC with ownership of 82,117,875, which is approximately 1.844% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 71,709,856 shares of the stock with an approximate value of $38.84 billion in UNH stocks shares; and FMR LLC, currently with $26.98 billion in UNH stock with ownership of nearly 2.045% of the company’s market capitalization.
Positions in UnitedHealth Group Incorporated stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 1,370 institutional holders increased their position in UnitedHealth Group Incorporated [NYSE:UNH] by around 34,003,941 shares. Additionally, 1,362 investors decreased positions by around 30,509,455 shares, while 365 investors held positions by with 761,057,980 shares. The mentioned changes placed institutional holdings at 825,571,376 shares, according to the latest SEC report filing. UNH stock had 155 new institutional investments in for a total of 2,250,366 shares, while 119 institutional investors sold positions of 3,616,139 shares during the same period.